Background: Exclusive enteral nutrition (EEN) is the first choice to induce remission and promote mucosal healing in pediatric Crohn's disease (CD). However, full adherence to EEN treatment may be problematic for children with CD. Methods: The goal of the current multicenter retrospective study was to define predictive factors of nonadherence to treatment and nonremission at the end of induction treatment. Those data together were analyzed with the ultimate goal of trying to define an individualized induction treatment for children with CD. Results: Three hundred seventy-six children with CD from 14 IBD pediatric referral centers were enrolled in the study. The rate of EEN adherence was 89%. Colonic involvement and fecal calprotectin >600 μg/g at diagnosis were found to be associated with a reduced EEN adherence. Exclusive enteral nutrition administered for 8 weeks was effective for inducing clinical remission in 67% of the total cohort. Factors determining lower remission rates were age >15 years and Pediatric Crohn's Disease Activity Index >50. Conclusion: Although EEN is extremely effective in promoting disease remission, several patients' related factors may adversely impact EEN adherence and response. Personalized treatments should be proposed that weigh benefits and risks based on the patient's disease location, phenotype, and disease activity and aim to promote a rapid control of inflammation to reduce long-term bowel damage.

Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn’s Disease: Determinants of Higher Adherence and Response / Cuomo, Marialaura; Carobbio, Alessandra; Aloi, Marina; Alvisi, Patrizia; Banzato, Claudia; Bosa, Luca; Bramuzzo, Matteo; Campanozzi, Angelo; Catassi, Giulia; D’Antiga, Lorenzo; Di Paola, Monica; Felici, Enrico; Fioretti, Maria Teresa; Gatti, Simona; Graziano, Francesco; Lega, Sara; Lionetti, Paolo; Marseglia, Antonio; Martinelli, Massimo; Musto, Francesca; Sansotta, Naire; Scarallo, Luca; Zuin, Giovanna; Norsa, Lorenzo. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 29:9(2023), pp. 1380-1389. [10.1093/ibd/izac215]

Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn’s Disease: Determinants of Higher Adherence and Response

Carobbio, Alessandra;
2023

Abstract

Background: Exclusive enteral nutrition (EEN) is the first choice to induce remission and promote mucosal healing in pediatric Crohn's disease (CD). However, full adherence to EEN treatment may be problematic for children with CD. Methods: The goal of the current multicenter retrospective study was to define predictive factors of nonadherence to treatment and nonremission at the end of induction treatment. Those data together were analyzed with the ultimate goal of trying to define an individualized induction treatment for children with CD. Results: Three hundred seventy-six children with CD from 14 IBD pediatric referral centers were enrolled in the study. The rate of EEN adherence was 89%. Colonic involvement and fecal calprotectin >600 μg/g at diagnosis were found to be associated with a reduced EEN adherence. Exclusive enteral nutrition administered for 8 weeks was effective for inducing clinical remission in 67% of the total cohort. Factors determining lower remission rates were age >15 years and Pediatric Crohn's Disease Activity Index >50. Conclusion: Although EEN is extremely effective in promoting disease remission, several patients' related factors may adversely impact EEN adherence and response. Personalized treatments should be proposed that weigh benefits and risks based on the patient's disease location, phenotype, and disease activity and aim to promote a rapid control of inflammation to reduce long-term bowel damage.
2023
29
9
1380
1389
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn’s Disease: Determinants of Higher Adherence and Response / Cuomo, Marialaura; Carobbio, Alessandra; Aloi, Marina; Alvisi, Patrizia; Banzato, Claudia; Bosa, Luca; Bramuzzo, Matteo; Campanozzi, Angelo; Catassi, Giulia; D’Antiga, Lorenzo; Di Paola, Monica; Felici, Enrico; Fioretti, Maria Teresa; Gatti, Simona; Graziano, Francesco; Lega, Sara; Lionetti, Paolo; Marseglia, Antonio; Martinelli, Massimo; Musto, Francesca; Sansotta, Naire; Scarallo, Luca; Zuin, Giovanna; Norsa, Lorenzo. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 29:9(2023), pp. 1380-1389. [10.1093/ibd/izac215]
Cuomo, Marialaura; Carobbio, Alessandra; Aloi, Marina; Alvisi, Patrizia; Banzato, Claudia; Bosa, Luca; Bramuzzo, Matteo; Campanozzi, Angelo; Catassi, Giulia; D’Antiga, Lorenzo; Di Paola, Monica; Felici, Enrico; Fioretti, Maria Teresa; Gatti, Simona; Graziano, Francesco; Lega, Sara; Lionetti, Paolo; Marseglia, Antonio; Martinelli, Massimo; Musto, Francesca; Sansotta, Naire; Scarallo, Luca; Zuin, Giovanna; Norsa, Lorenzo
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1332058
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 6
social impact